Answers are grounded in this paper and cite their sources.
Interleukin-6 (IL-6) is known to promote tumour growth and survival. We evaluated IL-6 gene amplification in tumours from 53 glioma patients using fluorescence in situ hybridisation. Amplification events were detected only in glioblastomas (15 out of 36 cases), the most malignant tumours, and were significantly associated with decreased patient survival.
No takes yet. Share an insight, caveat, or question.
Tchirkov et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: